Latest Lead News

TruScreen Group Limited reported a 19% revenue decline in FY2025 due to delayed rollouts in key emerging markets but anticipates a strong rebound with FY2026 sales forecast to exceed NZ$2.8 million.

Rhythm Biosciences has successfully validated its second-generation ColoSTAT® Beta assay, confirming its readiness for commercial application in colorectal cancer detection. The Beta kit offers improved precision and faster turnaround times compared to its predecessor.

Canyon Resources has locked in a US$140 million syndicated credit facility alongside a AU$24.5 million option exercise by a major shareholder, positioning the company to fast-track operations at its Minim Martap Bauxite Project in Cameroon.

Horizon Minerals has raised A$30 million through a two-tranche share placement, strengthening its balance sheet to fast-track exploration and processing upgrades. The capital injection aims to boost resource drilling and refurbish the Black Swan plant ahead of increased gold production.

WiseTech Global has announced its acquisition of E2open Parent Holdings, Inc. for $2.1 billion, significantly broadening its footprint in global trade and logistics software. The deal is expected to accelerate WiseTech’s vision of becoming the operating system for global trade and logistics.

WiseTech Global has announced a $2.1 billion acquisition of US-based e2open, aiming to create a comprehensive global trade and logistics marketplace. The deal, fully debt-funded and expected to close in the first half of 2026, promises to expand WiseTech’s product suite, customer base, and market reach.

AuMEGA Metals has launched an ambitious diamond drilling program at its Cape Ray and Bunker Hill projects in Newfoundland, revealing encouraging early gold results that hint at a larger mineralised system.

South Africa’s Minister of Mineral Resources has upheld Renergen’s helium extraction rights at the Virginia Gas Project, rejecting an appeal from Springbok Solar and securing the company’s production future.

Red Mountain Mining has visually confirmed an extensive antimony mineral system with stibnite veins stretching over 1km at its Armidale project in New South Wales, positioning the company to benefit from soaring antimony prices.

Immutep’s novel immunotherapy combination with radiotherapy and KEYTRUDA® has met its primary endpoint in a Phase II trial for resectable soft tissue sarcoma, showing promising early signs of improved patient outcomes.

Proteomics International has validated its PromarkerEndo blood test as a highly accurate, non-invasive diagnostic tool for endometriosis, with commercial launch planned in Australia for Q3 2025. The test promises to reduce the average seven-year diagnostic delay by providing a simple risk score applicable across all disease stages.

GreenHy2 Limited has broadened its renewable energy storage portfolio by integrating graphene-based hybrid supercapacitor batteries, reporting robust FY24 growth and advancing key customer trials.